Loading…
Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug
PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first...
Saved in:
Published in: | iScience 2020-07, Vol.23 (7), p.101262, Article 101262 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293 |
---|---|
cites | cdi_FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293 |
container_end_page | |
container_issue | 7 |
container_start_page | 101262 |
container_title | iScience |
container_volume | 23 |
creator | Miller, Maya Mellul, Anna Braun, Maya Sherill-Rofe, Dana Cohen, Emiliano Shpilt, Zohar Unterman, Irene Braitbard, Ori Hochman, Jacob Tshuva, Edit Y. Tabach, Yuval |
description | PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs.
[Display omitted]
•First in-depth mechanistic analysis of a non-toxic Ti-based anticancer metallodrug•A comprehensive RNA-seq analysis to map the transcriptomic netowrk initiated by phenolaTi.•Unraveling a distinct mechanism through ER stress, not through direct DNA binding•Toward understanding and applicability of diverse better-tolerable chemotherapies
Organometallic Chemistry; Biochemistry; Genomics; Cancer |
doi_str_mv | 10.1016/j.isci.2020.101262 |
format | article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1e1aa86012944e248f2c9a8a4d91867f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S258900422030448X</els_id><doaj_id>oai_doaj_org_article_1e1aa86012944e248f2c9a8a4d91867f</doaj_id><sourcerecordid>32585595</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293</originalsourceid><addsrcrecordid>eNp9kd1qGzEQhUVpaEKaF-hF0QvYlbTaH5VSMCFJAymF1L0WY2nkyN1dGUkbyNtXzrYmuemVhjlnPklzCPnA2ZIz3nzaLX0yfimYeG6IRrwhZ6Lu1IIxKd6-qE_JRUo7xoqTCamad-S0KmJdq_qMuLXPMPppoGswv3tMND8gvRpt2PeQBm_oPWZvpn4aPtMVvfYxZXqDYzhIP_Nkn2gYKdAjZjUWO4wGI_2OGfo-2Dht35MTB33Ci7_nOfl1fbW-_La4-3Fze7m6W5ha8LzYyA7Q1a5SViqugNuaV5VzrnOSt7BpVWfERkFtrG3bVqEC20ApVNWAFao6J7cz1wbY6X30A8QnHcDr50aIWw2xPLBHzZEDdE1ZnZISheycMAo6kFbxrmldYX2dWftpM6A1OOYI_Svoa2X0D3obHnVbCcFaWQBiBpgYUorojrOc6UOIeqcPIepDiHoOsQx9fHnrceRfZMXwZTZg2eOjx6gLAsvCrY9ocvmo_x__D5Asrv4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug</title><source>ScienceDirect (Online service)</source><source>PubMed Central</source><creator>Miller, Maya ; Mellul, Anna ; Braun, Maya ; Sherill-Rofe, Dana ; Cohen, Emiliano ; Shpilt, Zohar ; Unterman, Irene ; Braitbard, Ori ; Hochman, Jacob ; Tshuva, Edit Y. ; Tabach, Yuval</creator><creatorcontrib>Miller, Maya ; Mellul, Anna ; Braun, Maya ; Sherill-Rofe, Dana ; Cohen, Emiliano ; Shpilt, Zohar ; Unterman, Irene ; Braitbard, Ori ; Hochman, Jacob ; Tshuva, Edit Y. ; Tabach, Yuval</creatorcontrib><description>PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs.
[Display omitted]
•First in-depth mechanistic analysis of a non-toxic Ti-based anticancer metallodrug•A comprehensive RNA-seq analysis to map the transcriptomic netowrk initiated by phenolaTi.•Unraveling a distinct mechanism through ER stress, not through direct DNA binding•Toward understanding and applicability of diverse better-tolerable chemotherapies
Organometallic Chemistry; Biochemistry; Genomics; Cancer</description><identifier>ISSN: 2589-0042</identifier><identifier>EISSN: 2589-0042</identifier><identifier>DOI: 10.1016/j.isci.2020.101262</identifier><identifier>PMID: 32585595</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biochemistry ; Cancer ; Genomics ; Organometallic Chemistry</subject><ispartof>iScience, 2020-07, Vol.23 (7), p.101262, Article 101262</ispartof><rights>2020 The Authors</rights><rights>Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>2020 The Authors 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293</citedby><cites>FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322074/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S258900422030448X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32585595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miller, Maya</creatorcontrib><creatorcontrib>Mellul, Anna</creatorcontrib><creatorcontrib>Braun, Maya</creatorcontrib><creatorcontrib>Sherill-Rofe, Dana</creatorcontrib><creatorcontrib>Cohen, Emiliano</creatorcontrib><creatorcontrib>Shpilt, Zohar</creatorcontrib><creatorcontrib>Unterman, Irene</creatorcontrib><creatorcontrib>Braitbard, Ori</creatorcontrib><creatorcontrib>Hochman, Jacob</creatorcontrib><creatorcontrib>Tshuva, Edit Y.</creatorcontrib><creatorcontrib>Tabach, Yuval</creatorcontrib><title>Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug</title><title>iScience</title><addtitle>iScience</addtitle><description>PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs.
[Display omitted]
•First in-depth mechanistic analysis of a non-toxic Ti-based anticancer metallodrug•A comprehensive RNA-seq analysis to map the transcriptomic netowrk initiated by phenolaTi.•Unraveling a distinct mechanism through ER stress, not through direct DNA binding•Toward understanding and applicability of diverse better-tolerable chemotherapies
Organometallic Chemistry; Biochemistry; Genomics; Cancer</description><subject>Biochemistry</subject><subject>Cancer</subject><subject>Genomics</subject><subject>Organometallic Chemistry</subject><issn>2589-0042</issn><issn>2589-0042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kd1qGzEQhUVpaEKaF-hF0QvYlbTaH5VSMCFJAymF1L0WY2nkyN1dGUkbyNtXzrYmuemVhjlnPklzCPnA2ZIz3nzaLX0yfimYeG6IRrwhZ6Lu1IIxKd6-qE_JRUo7xoqTCamad-S0KmJdq_qMuLXPMPppoGswv3tMND8gvRpt2PeQBm_oPWZvpn4aPtMVvfYxZXqDYzhIP_Nkn2gYKdAjZjUWO4wGI_2OGfo-2Dht35MTB33Ci7_nOfl1fbW-_La4-3Fze7m6W5ha8LzYyA7Q1a5SViqugNuaV5VzrnOSt7BpVWfERkFtrG3bVqEC20ApVNWAFao6J7cz1wbY6X30A8QnHcDr50aIWw2xPLBHzZEDdE1ZnZISheycMAo6kFbxrmldYX2dWftpM6A1OOYI_Svoa2X0D3obHnVbCcFaWQBiBpgYUorojrOc6UOIeqcPIepDiHoOsQx9fHnrceRfZMXwZTZg2eOjx6gLAsvCrY9ocvmo_x__D5Asrv4</recordid><startdate>20200724</startdate><enddate>20200724</enddate><creator>Miller, Maya</creator><creator>Mellul, Anna</creator><creator>Braun, Maya</creator><creator>Sherill-Rofe, Dana</creator><creator>Cohen, Emiliano</creator><creator>Shpilt, Zohar</creator><creator>Unterman, Irene</creator><creator>Braitbard, Ori</creator><creator>Hochman, Jacob</creator><creator>Tshuva, Edit Y.</creator><creator>Tabach, Yuval</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200724</creationdate><title>Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug</title><author>Miller, Maya ; Mellul, Anna ; Braun, Maya ; Sherill-Rofe, Dana ; Cohen, Emiliano ; Shpilt, Zohar ; Unterman, Irene ; Braitbard, Ori ; Hochman, Jacob ; Tshuva, Edit Y. ; Tabach, Yuval</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biochemistry</topic><topic>Cancer</topic><topic>Genomics</topic><topic>Organometallic Chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miller, Maya</creatorcontrib><creatorcontrib>Mellul, Anna</creatorcontrib><creatorcontrib>Braun, Maya</creatorcontrib><creatorcontrib>Sherill-Rofe, Dana</creatorcontrib><creatorcontrib>Cohen, Emiliano</creatorcontrib><creatorcontrib>Shpilt, Zohar</creatorcontrib><creatorcontrib>Unterman, Irene</creatorcontrib><creatorcontrib>Braitbard, Ori</creatorcontrib><creatorcontrib>Hochman, Jacob</creatorcontrib><creatorcontrib>Tshuva, Edit Y.</creatorcontrib><creatorcontrib>Tabach, Yuval</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>iScience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miller, Maya</au><au>Mellul, Anna</au><au>Braun, Maya</au><au>Sherill-Rofe, Dana</au><au>Cohen, Emiliano</au><au>Shpilt, Zohar</au><au>Unterman, Irene</au><au>Braitbard, Ori</au><au>Hochman, Jacob</au><au>Tshuva, Edit Y.</au><au>Tabach, Yuval</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug</atitle><jtitle>iScience</jtitle><addtitle>iScience</addtitle><date>2020-07-24</date><risdate>2020</risdate><volume>23</volume><issue>7</issue><spage>101262</spage><pages>101262-</pages><artnum>101262</artnum><issn>2589-0042</issn><eissn>2589-0042</eissn><abstract>PhenolaTi is an advanced non-toxic anticancer chemotherapy; this inert bis(phenolato)bis(alkoxo) Ti(IV) complex demonstrates the intriguing combination of high and wide efficacy with no detected toxicity in animals. Here we unravel the cellular pathways involved in its mechanism of action by a first genome study on Ti(IV)-treated cells, using an attuned RNA sequencing-based available technology. First, phenolaTi induced apoptosis and cell-cycle arrest at the G2/M phase in MCF7 cells. Second, the transcriptome of the treated cells was analyzed, identifying alterations in pathways relating to protein translation, DNA damage, and mitochondrial eruption. Unlike for common metallodrugs, electrophoresis assay showed no inhibition of DNA polymerase activity. Reduced in vitro cytotoxicity with added endoplasmic reticulum (ER) stress inhibitor supported the ER as a putative cellular target. Altogether, this paper reveals a distinct ER-related mechanism by the Ti(IV) anticancer coordination complex, paving the way for wider applicability of related techniques in mechanistic analyses of metallodrugs.
[Display omitted]
•First in-depth mechanistic analysis of a non-toxic Ti-based anticancer metallodrug•A comprehensive RNA-seq analysis to map the transcriptomic netowrk initiated by phenolaTi.•Unraveling a distinct mechanism through ER stress, not through direct DNA binding•Toward understanding and applicability of diverse better-tolerable chemotherapies
Organometallic Chemistry; Biochemistry; Genomics; Cancer</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32585595</pmid><doi>10.1016/j.isci.2020.101262</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2589-0042 |
ispartof | iScience, 2020-07, Vol.23 (7), p.101262, Article 101262 |
issn | 2589-0042 2589-0042 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_1e1aa86012944e248f2c9a8a4d91867f |
source | ScienceDirect (Online service); PubMed Central |
subjects | Biochemistry Cancer Genomics Organometallic Chemistry |
title | Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A39%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Titanium%20Tackles%20the%20Endoplasmic%20Reticulum:%20A%20First%20Genomic%20Study%20on%20a%20Titanium%20Anticancer%20Metallodrug&rft.jtitle=iScience&rft.au=Miller,%20Maya&rft.date=2020-07-24&rft.volume=23&rft.issue=7&rft.spage=101262&rft.pages=101262-&rft.artnum=101262&rft.issn=2589-0042&rft.eissn=2589-0042&rft_id=info:doi/10.1016/j.isci.2020.101262&rft_dat=%3Cpubmed_doaj_%3E32585595%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c521t-b48aef5f39d4919a1d5133fff8f417ab798c2b9a5cdd7779e9ad6a779936ad293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/32585595&rfr_iscdi=true |